PRNewsWire
24 Jul 2026, 07:03 UTC · 3h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
Valmet's orders received in Q2 2026 declined by 10% year-over-year, and the total order backlog fell by 10% to 4.26 billion EUR. — A double-digit decline in new orders and backlog suggests weakening future revenue streams and reduced demand for the company's core solutions.
-0.60Valmet's short-term market outlook for July–December 2026 indicates that the biomaterial services market is expected to remain soft and overall market visibility is low due to geopolitical and economic uncertainty. — Negative sentiment regarding the second half of the year suggests headwinds for growth and potential pressure on the reiterated guidance.
-0.40The company's Q2 net sales increased by 6% to 1.315 billion EUR, and Comparable EBITA rose 6% to 152 million EUR. — Short-term growth in sales and operating profit shows the company is successfully executing existing orders.
+0.30Continue reading
6 related stories
Top 1 mover · tap to explore
Valmet reiterated its 2026 full-year guidance, estimating net sales to remain flat at approximately 5.2 billion EUR and Comparable EBITA to remain flat or increase compared to 2025. — Maintaining guidance provides stability and a floor for investor expectations despite the drop in new orders.
+0.20Which stocks this story touches
The company reported increases in net sales, Comparable EBITA, and profit for the period, although orders received declined.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Seeking Alpha
2h ago
